STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

STYK1 promotes cancer cell proliferation and malignant transformation by activating PI3K-AKT pathway in gallbladder carcinoma

Published:2018-04 Issue: Volume:97 Page:16-27
ISSN:1357-2725
Container-title:The International Journal of Biochemistry & Cell Biology
language:en
Short-container-title:The International Journal of Biochemistry & Cell Biology

Author:

Hu Yun-ping,Wu Zeng-bin,Jiang Lin,Jin Yun-peng,Li Huai-feng,Zhang Yi-jian,Ma Qiang,Ye Yuan-yuan,Wang Zheng,Liu Yong-chen,Chen Hong-zhuan,Liu Ying-bin

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry

Reference29 articles.

1. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers;Amachika;Lung Cancer,2007

2. Gallbladder cancer in India: a dismal picture;Batra;J. Gastroenterol. Hepatol.,2005

3. Emerging roles of pseudokinases;Boudeau;Trends Cell Biol.,2006

4. Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice;Chen;Cancer Res.,2005

5. Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer;Chen;BMC Cancer,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell RNA-sequencing Analysis Reveals the Promoting Role of the Hedgehog Pathway in Epithelial Cells during Cervical Cancer Progression;Current Medicinal Chemistry;2024-08-26

2. Topological reorganization and functional alteration of distinct genomic components in gallbladder cancer;Frontiers of Medicine;2023-09-18

3. Targeted Therapies in Gallbladder Cancer: Current Status and Future Perspectives;Gallbladder Cancer;2023

4. Differential Transcriptomic Profiles Following Stimulation with Lipopolysaccharide in Intestinal Organoids from Dogs with Inflammatory Bowel Disease and Intestinal Mast Cell Tumor;Cancers;2022-07-20

5. The EGFR-STYK1-FGF1 axis sustains functional drug tolerance to EGFR inhibitors in EGFR-mutant non-small cell lung cancer;Cell Death & Disease;2022-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3